Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Leukemia & Lymphoma
|
January 11, 2019
Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis
Zeina Al-Mansour, Hongli Li, James R Cook, et al.
The New England Journal of Medicine
|
November 1, 2013
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma
Patrick J Stiff, Joseph M Unger, James R Cook, et al.
Blood
|
June 22, 2021
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study
Mitchell E Horwitz, Patrick J Stiff, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 26, 2018
Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation
Patrick J Stiff, Pau Montesinos, Tony Peled, et al.
British Journal of Haematology
|
September 28, 2021
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation
Peter A Riedell, Mehdi Hamadani, Kwang W Ahn, et al.
Cancer Immunology, Immunotherapy : CII
|
December 22, 2017
Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells
Tamson Moore, Courtney Regan Wagner, Gina M Scurti, et al.
Journal for Immunotherapy of Cancer
|
August 30, 2023
Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
Bijal D Shah, Ryan D Cassaday, Jae H Park, et al.
Cancer Immunology, Immunotherapy : CII
|
October 21, 2017
Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells
Tamson Moore, Courtney Regan Wagner, Gina M Scurti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2021
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia
Pinkal M Desai, Janice Brown, Saar Gill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 4, 2019
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients
Roy F Chemaly, Sanjeet S Dadwal, Anne Bergeron, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Leukemia & Lymphoma
|
January 11, 2019
Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis
Zeina Al-Mansour, Hongli Li, James R Cook, et al.
The New England Journal of Medicine
|
November 1, 2013
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma
Patrick J Stiff, Joseph M Unger, James R Cook, et al.
Blood
|
June 22, 2021
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study
Mitchell E Horwitz, Patrick J Stiff, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 26, 2018
Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation
Patrick J Stiff, Pau Montesinos, Tony Peled, et al.
British Journal of Haematology
|
September 28, 2021
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation
Peter A Riedell, Mehdi Hamadani, Kwang W Ahn, et al.
Cancer Immunology, Immunotherapy : CII
|
December 22, 2017
Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells
Tamson Moore, Courtney Regan Wagner, Gina M Scurti, et al.
Journal for Immunotherapy of Cancer
|
August 30, 2023
Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
Bijal D Shah, Ryan D Cassaday, Jae H Park, et al.
Cancer Immunology, Immunotherapy : CII
|
October 21, 2017
Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells
Tamson Moore, Courtney Regan Wagner, Gina M Scurti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2021
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia
Pinkal M Desai, Janice Brown, Saar Gill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 4, 2019
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients
Roy F Chemaly, Sanjeet S Dadwal, Anne Bergeron, et al.
Page
of 8